DGM
AMAM
Darwin Global Management’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-16,688,636
| Closed | -$238M | – | 17 |
|
|
2023
Q4 | $238M | Hold |
16,688,636
| – | – | 46.64% | 1 |
|
|
2023
Q3 | $192M | Hold |
16,688,636
| – | – | 67.54% | 1 |
|
|
2023
Q2 | $275M | Buy |
16,688,636
+5,384,063
| +48% | +$88.6M | 44.91% | 1 |
|
|
2023
Q1 | $101M | Buy |
11,304,573
+3,720,084
| +49% | +$33.2M | 27.58% | 3 |
|
|
2022
Q4 | $17.2M | Buy |
+7,584,489
| New | +$17.2M | 10.72% | 3 |
|